Zev Handelman
About Zev Handelman
Zev Handelman serves as the Vice President of Sales and Marketing and Commercial Launch Leader at Day One Biopharmaceuticals, where he has worked since 2022. He has over a decade of experience in the life sciences sector, particularly in oncology, and has a strong background in managing team performance and culture.
Current Role at Day One Biopharmaceuticals
Zev Handelman serves as the Vice President of Sales and Marketing and Commercial Launch Leader at Day One Biopharmaceuticals. He has held this position since 2022, contributing to the company's strategic initiatives in South San Francisco, California. In this role, he focuses on driving sales strategies and marketing efforts to support the commercial launch of products.
Previous Experience at Day One Biopharmaceuticals
Prior to his current role, Handelman worked at Day One Biopharmaceuticals as the Interim Chief Commercial Officer for 10 months from 2022 to 2023. He also served as the Vice President of Marketing and Commercial Launch Leader from 2021 to 2022. His tenure at the company involved leading marketing strategies and overseeing product launches.
Career Background in Life Sciences
Zev Handelman has over 10 years of experience in the life sciences sector, particularly in oncology, infectious disease, pulmonology, and dermatology. His previous roles include serving as Marketing Director for both the Pulmozyme and Oncology Pipeline at Genentech, where he managed marketing strategies and product positioning.
Educational Background
Handelman studied at the University of California, Berkeley, where he earned a Master of Public Health (MPH) in Healthcare Management from 2001 to 2003. He also obtained a Master of Business Administration (MBA) in Healthcare Policy and Management from the Haas School of Business at the same institution during the same period. Earlier, he completed a Bachelor of Arts in History at Duke University from 1992 to 1996.
Achievements in Product Launches
Throughout his career, Zev Handelman has successfully driven three product launches and five follow-on indications in the life sciences sector. He leads pipeline and lifecycle strategy teams to maximize long-term brand value, demonstrating his expertise in managing performance and fostering a healthy team culture.